Journal
TRANSPLANTATION
Volume 93, Issue 7, Pages 723-728Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e3182472876
Keywords
Cytomegalovirus; Hepatitis C virus; Liver transplantation; Death; Graft loss
Categories
Ask authors/readers for more resources
Background. Cytomegalovirus (CMV) has been inconsistently associated with recurrent hepatitis C virus (HCV) after liver transplant (LT). Methods. A retrospective study of 347, donor or recipient CMV seropositive, first LT recipients transplanted for HCV was performed to evaluate the associations of CMV infection and disease occurring within 1-year of LT with the primary endpoints of allograft inflammation grade >= 2 and fibrosis stage >= 2. Associations were evaluated using multivariable Cox regression models. Results. CMV infection and disease occurred in 111 (32%) and 24 (7%) patients, respectively. Hepatic allograft inflammation grade >= 2 and fibrosis stage >= 2 occurred in 221 (64%) and 140 (40%) patients, respectively. CMV infection was associated with increased risk of fibrosis stage >= 2 (relative risk [RR], 1.52; P=0.033). CMV disease was associated with increased risk of inflammation grade >= 2 (RR, 3.40; P<0.001), and although not significant, with fibrosis stage >= 2 (RR, 2.03; P=0.052). These associations did not differ significantly according to recipient CMV seropositivity. Conclusions. Our results support an association between CMV infection and disease with recurrence of HCV after LT. Investigation of prevention of CMV infection and disease as a strategy to mitigate recurrent HCV in LT recipients is warranted.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available